Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FN4LM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,117
Award facts
- Contract value 100% obligated
- $41,116.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,116.91 delivery order to AmerisourceBergen Drug Corp for 30-count packages of Vraylar 1.5 mg capsules, a pharmaceutical product used in the treatment of psychiatric conditions. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement running through December 2026 that serves as a comprehensive global vehicle for supplying medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare procurement. The company's DLA Troop Support Medical contract enables it to supply an extensive portfolio of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Vraylar represents one of numerous individual orders fulfilled under the broader IDC framework, demonstrating the company's capacity to meet federal medical supply requirements through competitive contracting processes.
Quick answers
Who was awarded contract SPE2DB25FN4LM?
SPE2DB25FN4LM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FN4LM worth?
The government has obligated $41,117 on SPE2DB25FN4LM.
Is contract SPE2DB25FN4LM an order under another contract?
Yes. SPE2DB25FN4LM is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4LM competed?
The extent of competition for SPE2DB25FN4LM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award